These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Helman AM; Murphy MP Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178 [TBL] [Abstract][Full Text] [Related]
6. Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment. Fulop GA; Tarantini S; Yabluchanskiy A; Molnar A; Prodan CI; Kiss T; Csipo T; Lipecz A; Balasubramanian P; Farkas E; Toth P; Sorond F; Csiszar A; Ungvari Z Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1124-H1140. PubMed ID: 30848677 [TBL] [Abstract][Full Text] [Related]
7. Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis. Bickel MA; Csik B; Gulej R; Ungvari A; Nyul-Toth A; Conley SM Front Endocrinol (Lausanne); 2023; 14():1087053. PubMed ID: 36755922 [TBL] [Abstract][Full Text] [Related]
8. Age-related impairment of neurovascular coupling responses: a dynamic vessel analysis (DVA)-based approach to measure decreased flicker light stimulus-induced retinal arteriolar dilation in healthy older adults. Lipecz A; Csipo T; Tarantini S; Hand RA; Ngo BN; Conley S; Nemeth G; Tsorbatzoglou A; Courtney DL; Yabluchanska V; Csiszar A; Ungvari ZI; Yabluchanskiy A Geroscience; 2019 Jun; 41(3):341-349. PubMed ID: 31209739 [TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design. BenAri O; Efrati S; Sano M; Bendlin BB; Lin H; Liu X; Sela I; Almog G; Livny A; Sandler I; Ben-Haim S; Sagi R; LeRoith D; Schnaider Beeri M; Ravona-Springer R Alzheimers Dement (N Y); 2020; 6(1):e12008. PubMed ID: 32296731 [TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer's disease mouse model and in elderly patients. Shapira R; Gdalyahu A; Gottfried I; Sasson E; Hadanny A; Efrati S; Blinder P; Ashery U Aging (Albany NY); 2021 Sep; 13(17):20935-20961. PubMed ID: 34499614 [TBL] [Abstract][Full Text] [Related]
11. Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline. de Montgolfier O; Thorin-Trescases N; Thorin E Am J Hypertens; 2020 Apr; 33(5):375-390. PubMed ID: 32202623 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APP Yang C; Liu G; Zeng X; Xiang Y; Chen X; Le W Redox Biol; 2024 Apr; 70():103006. PubMed ID: 38241837 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase. Toth P; Tarantini S; Tucsek Z; Ashpole NM; Sosnowska D; Gautam T; Ballabh P; Koller A; Sonntag WE; Csiszar A; Ungvari Z Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H299-308. PubMed ID: 24322615 [TBL] [Abstract][Full Text] [Related]
14. The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Yang T; Sun Y; Lu Z; Leak RK; Zhang F Ageing Res Rev; 2017 Mar; 34():15-29. PubMed ID: 27693240 [TBL] [Abstract][Full Text] [Related]
15. Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease. Csiszar A; Tarantini S; Fülöp GA; Kiss T; Valcarcel-Ares MN; Galvan V; Ungvari Z; Yabluchanskiy A Geroscience; 2017 Aug; 39(4):359-372. PubMed ID: 28853030 [TBL] [Abstract][Full Text] [Related]